PATENT CLAIM ANALYSIS

Application Number: 15766029
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["424", "049000"]

Abstract:
A bactericidal and virucidal pharmaceutical composition for use on epithelial tissues such as pulmonary, nasal and oral tissues, which comprises a non-steroidal anti-inflammatory drug (NSAID) in a concentration between 5 and 500 mM and a salt, being the NSAID preferably solubilized in a hypertonic saline solution applicable in therapies for viral infections of the Herpes simplex type. The composition can be used in therapies for herpes simplex viral infections, be used as a bactericidal mouthwash, or be vehiculated to the lung by using a nebuliser, for cystic fibrosis.

Claim (Index 21):
The composition of  claim 1 , wherein said composition comprises a pharmaceutical formulation for nebulising patients suffering from cystic fibrosis.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 91.0
- Lexical Diversity: 1.53125
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['11249051', '14069001', '12995125', '14791210', '13605734']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7283276282603732
- 35 USC 102 Novelty (BERT): 0.5046062339267344
- Combined Prediction Score: 0.7059554888270093
- Mean Citation Score: 198.27391
- Max Citation Score: 210.70003
- Similarity Product: 128.42971650306106

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test